Sanjing Pharmaceutical Related Events

According to reports, Sanjing Pharmaceutical Co., Ltd. and Harbin Pharmaceutical Co., Ltd. announced at the same time on the evening of May 19 that Liu Zhanbin, the current chairman of Sanjing Pharmaceutical Co., Ltd., was put on file for investigation on suspicion of accepting bribes and jumped to his death.

Sanjing Pharmaceutical announced that Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. received a notice from Heihe People's Procuratorate on May 18 that Liu Zhanbin, the chairman of the company, was placed on file for investigation on May 16. After breakfast on May 18, Liu Zhanbin said he was unwell. On the morning of the same day, during the physical examination of Xunke County Hospital, he got rid of the guardianship bailiff in the bathroom on the third floor and jumped out of the window and fell to the ground to die.

Since Liu Zhanbin is a director of Harbin Pharmaceutical Co., Ltd., Harbin Pharmaceutical Co., Ltd. also announced the same content mentioned above. 19, it is reported in the industry that Liu Zhanbin was taken away by the procuratorate to assist in the investigation on suspicion of corruption and bribery, and committed suicide by jumping off a building in the hospital on the grounds that he was unwell and asked for treatment.

According to public information, Liu Zhanbin is 5 1 year old this year.

In 2009, major personnel changes occurred in the top management of Harbin Pharmaceutical Group. Jiang Linkui, the chairman of Sanjing Pharmaceutical, was transferred, and Wang Jianbo, the former general manager, resigned and left. Liu Zhanbin, former chairman and general manager of Harbin Pharmaceutical Group Chinese Medicine Co., Ltd., became the chairman and general manager of Sanjing Pharmaceutical.

However, in 2065438+2002, 65438+ 10, the senior management of Harbin Pharmaceutical Co., Ltd. made another personnel adjustment. Liu Zhanbin ceased to be the general manager of Sanjing Pharmaceutical Co., Ltd. and was replaced by Liu Chunfeng. Liu Zhanbin is still the chairman.

The product structure of Sanjing Pharmaceutical Co., Ltd. is mainly OTC (over-the-counter medicine) and health food, and it is famous in the industry for its "advertising+conference" marketing model. However, in recent years, the OTC market as a whole is not prosperous, and the operating mode of OTC category "channel+advertising" is unsustainable.